Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Anti-infective Drugs	3.03B
Anti-infective Drugs Growth	-52.23%
Chronic Disease Treatment Drugs	1.16B
Chronic Disease Treatment Drugs Growth	80.40%
Other	166.50M
Other Growth	155.12%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
China	4.21B
China Growth	-39.91%
United Kingdom	94.28M
United States	26.80M
United States Growth	65.72%
Germany	25.49M
Germany Growth	-28.88%
Other Countries	3.52M
Other Countries Growth	20.30%